ACTI-PANTOTHENIC ACID 300 CAPLET 300MG 300 MG — DIN 01900692
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 300 MG · ACTI-FORM LTD. · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ACTI-PANTOTHENIC ACID 300 CAPLET 300MG?
ACTI-PANTOTHENIC ACID 300 CAPLET 300MG 300 MG contains D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 300 MG. It is listed in the Health Canada Drug Product Database under DIN 01900692, held by ACTI-FORM LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Mar-2005. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Calcium Pantothenate in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Calcium Pantothenate, across 32 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| GAHLER ENTERPRISES LTD. | 3 | 0 | D PANTOTHENIC ACID TAB 100MG, D-PANTOTHENIC ACID 250MG CAP, D'PANTOTHENIC ACID SRT 1000MG | No marketed DIN |
| GREAT EARTH COMPANIES, INC. | 3 | 0 | PANTOTHENIC ACID 100MG, PANTOTHENIC ACID 250MG, PANTOTHENIC ACID 500MG | No marketed DIN |
| ACTI-FORM LTD. | 2 | 0 | ACTI PANTOTHENIC ACID 1000 TIMED CAPLET, ACTI-PANTOTHENIC ACID 300 CAPLET 300MG | No marketed DIN |
| GENERAL NUTRITION CANADA INC. | 2 | 0 | PANTOTHENIC ACID 100 MG TABLETS, PANTOTHENIC ACID 250MG | No marketed DIN |
| ICN CANADA LTD. | 2 | 0 | CALPAN TAB 100MG, CALPAN TAB 250MG | No marketed DIN |
| NU-LIFE NUTRITION LTD. | 2 | 0 | PANTOTHENIC ACID TAB 100MG NU LIFE, PANTOTHENIC ACID TABLETS 300MG | No marketed DIN |
| NUTRI-WEST PRODUCTS LTD. | 2 | 0 | PANTOTHENIC ACID TAB 250MG, PANTOTHENIC ACID-S TAB 100MG | No marketed DIN |
| TWIN LABORATORIES INC. | 2 | 0 | PANTOTHENIC ACID CAPS 100MG, PANTOTHENIC ACID CAPS 250MG | No marketed DIN |
| LES PRODUITS NATURELS SUISSE INC. | 1 | 0 | PANTACID TAB 250MG | No marketed DIN |
| PURE LIFE INTERNATIONAL PRODS INC. | 1 | 0 | PANTOTHENIC ACID TAB 500MG | No marketed DIN |
| QUEST VITAMINS A DIV OF PURITY LIFE HEALTH PRODUCTS | 1 | 0 | PANTOTHENIC ACID CAP 250MG | No marketed DIN |
| SEROYAL INTERNATIONAL INC. | 1 | 0 | PANTOTHENIC ACID | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 300 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Calcium Pantothenate |
|---|---|
| ATC code | A11HA31 |
| AHFS class | 88:08.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01900692 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1900692 |
| Brand name | ACTI-PANTOTHENIC ACID 300 CAPLET 300MG |
| Generic / active ingredient | D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) : 300 MG |
| Market authorization holder | ACTI-FORM LTD. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A11HA31 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A11HA |
| Current status | CANCELLED POST MARKET |
| Status date | 21-Mar-2005 |
| Original market date | 1991-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Calcium Pantothenate in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for ACTI-PANTOTHENIC ACID 300 CAPLET 300MG
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 32 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTI PANTOTHENIC ACID 1000 TIMED CAPLET | 1 G | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | 01909614 |
| CALCIUM PANTOTHENATE TAB 250MG | 250 MG | TABLET | TROPHIC CANADA LTD. | CANCELLED POST MARKET | 01905708 |
| CALPAN TAB 100MG | 100 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | 00268615 |
| CALPAN TAB 250MG | 250 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | 00268623 |
| D PANTOTHENIC ACID TAB 100MG | 100 MG | TABLET | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 00619108 |
| D-PANTOTHENIC ACID 250MG | 250 MG | CAPSULE | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | 02243650 |
| D-PANTOTHENIC ACID 250MG CAP | 250 MG | CAPSULE | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 01941801 |
| D'PANTOTHENIC ACID SRT 1000MG | 1 G | TABLET (EXTENDED-RELEASE) | GAHLER ENTERPRISES LTD. | CANCELLED POST MARKET | 00535028 |
| PANTACID TAB 250MG | 250 MG | TABLET | LES PRODUITS NATURELS SUISSE INC. | CANCELLED POST MARKET | 00555398 |
| PANTOTHENIC ACID | 250 MG | CAPSULE | SEROYAL INTERNATIONAL INC. | CANCELLED POST MARKET | 01993909 |
2 · Same class — other molecules in ATC A11HA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pyridoxine (Vit B6) | ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 100 TAB · ACTI-PYRIDOXINE/PYRIDOXAL 5-PHOSPH 250 TAB · ACV · B-6 500MG CONTINUOUS RELEASED · +66 more | 82 | 1 | Yes |
| Tocopherol (Vit E) | ACTI-COPHEROLS 200 CAP · ACTI-D ALPHACOPHEROL CAP 400UNIT · ACTI-D ALPHACOPHEROL CAP 800UNIT · ACTI-SUCCINATE CAPLET 400UNIT · +185 more | 233 | 0 | Not in Canada |
| Calcium Pantothenate | ACTI PANTOTHENIC ACID 1000 TIMED CAPLET · ACTI-PANTOTHENIC ACID 300 CAPLET 300MG · CALCIUM PANTOTHENATE TAB 250MG · CALPAN TAB 100MG · +27 more | 32 | 0 | Not in Canada |
| Nicotinamide | B3 · NIACINAMIDE · NIACINAMIDE 100 MG TABLETS · NIACINAMIDE 100MG · +14 more | 26 | 0 | Not in Canada |
| Riboflavin (Vit B2) | ACTI-RIBO/RIBO 5-PHOSPH CAPLET · B-2 CAPS 100MG · B2 TAB 100MG · RIBOFLAVIN 5 PHOSPHATE CAP 50MG · +14 more | 18 | 0 | Not in Canada |
| Biotin | ACTI-BIOTIN 300 CAPLET 300MCG · BIOTIN 300 MCG - TABLET · BIOTIN 300 MCG TABLET · BIOTIN 300MCG · +6 more | 12 | 0 | Not in Canada |
| Pyridoxal Phosphate | PYRIDOXAL-5-PHOSPHATE-S TAB 25MG · ROYAL-T VITAMIN AND MINERAL SUPPLEMENT | 2 | 0 | Not in Canada |
| Inositol | INOSITOL 500MG · INOSITOLEX 400MGMS | 2 | 0 | Not in Canada |
| Tocofersolan | AQUASOL E TPGS LIQUID 77IU/ML | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.